CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-22 | Smith David Ross Corporate Executive VP & CFO | Option exercise · Stock Options (Right to Buy) | −3,845 | 3,846 | ||
| 2021-04-15 | Smith David Ross Corporate Executive VP & CFO | Sale | −2,000 | $320.00 | $640K | 14,862 |
| 2021-04-06 | Girshick Birgit Corporate Executive VP | Option exercise | +5,986 | $88.05 | $527K | 35,046 |
| 2021-04-06 | Girshick Birgit Corporate Executive VP | Sale | −5,986 | $298.00 | $1.8M | 29,060 |
| 2021-04-06 | Girshick Birgit Corporate Executive VP | Option exercise | +6,409 | $109.34 | $701K | 35,469 |
| 2021-04-06 | Girshick Birgit Corporate Executive VP | Sale | −6,409 | $304.85 | $2.0M | 29,060 |
| 2021-04-06 | Girshick Birgit Corporate Executive VP | Option exercise | +5,916 | $144.67 | $856K | 34,976 |
| 2021-04-06 | Girshick Birgit Corporate Executive VP | Sale | −5,916 | $304.85 | $1.8M | 29,060 |
| 2021-04-06 | Girshick Birgit Corporate Executive VP | Option exercise · Stock Options (Right to Buy) | −5,986 | 0 | ||
| 2021-04-06 | Girshick Birgit Corporate Executive VP | Option exercise · Stock Options (Right to Buy) | −6,409 | 3,205 | ||
| 2021-04-06 | Girshick Birgit Corporate Executive VP | Option exercise · Stock Options (Right to Buy) | −5,916 | 5,916 | ||
| 2021-04-05 | Girshick Birgit Corporate Executive VP | Option exercise | +999 | $88.05 | $88K | 30,059 |
| 2021-04-05 | Girshick Birgit Corporate Executive VP | Sale | −999 | $298.00 | $298K | 29,060 |
| 2021-04-05 | Girshick Birgit Corporate Executive VP | Option exercise · Stock Options (Right to Buy) | −999 | 5,986 | ||
| 2021-03-01 | Girshick Birgit Corporate Executive VP & COO | Gift | −350 | 28,710 | ||
| 2021-03-01 | MILNE GEORGE M JR Director | Option exercise | +3,530 | $52.29 | $185K | 31,947 |
| 2021-03-01 | MILNE GEORGE M JR Director | Sale | −3,530 | $290.01 | $1.0M | 28,417 |
| 2021-03-01 | MILNE GEORGE M JR Director | Option exercise · Stock Options (Right to Buy) | −3,530 | 0 | ||
| 2021-03-01 | Smith David Ross Corporate Executive VP & CFO | Option exercise | +4,366 | $88.05 | $384K | 21,228 |
| 2021-03-01 | Smith David Ross Corporate Executive VP & CFO | Sale | −4,366 | $290.12 | $1.3M | 16,862 |
Page 43 of 60 · 1,185 trades